Advanced Clinical Research represents the vanguard of medical exploration, going beyond conventional methodologies. It integrates state-of-the-art technologies like AI and big data, fostering a data-driven understanding of diseases. This interdisciplinary field unites genomics, pharmacology, and bioinformatics experts, promoting personalized medicine and targeted therapies. The emphasis on biomarkers and diagnostics enhances precision, enabling faster, more efficient clinical trials. Adaptive trial designs, a hallmark of Advanced Clinical Research, optimize resources and expedite drug development. The field also delves into the intricate role of the human microbiome, paving the way for therapies targeting the gut-brain axis.
Ethical considerations remain paramount, with a focus on patient-reported outcomes and active patient engagement. In essence, Advanced Clinical Research is reshaping the future of medicine, emphasizing innovation, efficiency, and patient-centricity in the relentless pursuit of improved healthcare outcomes. Advanced Clinical Research is a dynamic and forward-looking field that transcends traditional boundaries. Through the integration of cutting-edge technologies, interdisciplinary collaboration, and a patient-centric approach, researchers in this field are driving innovation and revolutionizing the landscape of healthcare. As the journey of discovery continues, the impact of Advanced Clinical Research is poised to shape the future of medicine, bringing hope and healing to patients around the globe.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico